Aneurysmal Subarachnoid Hemorrhage

Stanlies D'Souza, Stanlies D'Souza

Abstract

Aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden with high fatality and permanent disability rates. The overall prognosis depends on the volume of the initial bleed, rebleeding, and degree of delayed cerebral ischemia (DCI). Cardiac manifestations and neurogenic pulmonary edema indicate the severity of SAH. The International Subarachnoid Aneurysm Trial (ISAT) reported a favorable neurological outcome with the endovascular coiling procedure compared with surgical clipping at the end of 1 year. The ISAT trial recruits were primarily neurologically good grade patients with smaller anterior circulation aneurysms, and therefore the results cannot be reliably extrapolated to larger aneurysms, posterior circulation aneurysms, patients presenting with complex aneurysm morphology, and poor neurological grades. The role of hypothermia is not proven to be neuroprotective according to a large randomized controlled trial, Intraoperative Hypothermia for Aneurysms Surgery Trial (IHAST II), which recruited patients with good neurological grades. Patients in this trial were subjected to slow cooling and inadequate cooling time and were rewarmed rapidly. This methodology would have reduced the beneficial effects of hypothermia. Adenosine is found to be beneficial for transient induced hypotension in 2 retrospective analyses, without increasing the risk for cardiac and neurological morbidity. The neurological benefit of pharmacological neuroprotection and neuromonitoring is not proven in patients undergoing clipping of aneurysms. DCI is an important cause of morbidity and mortality following SAH, and the pathophysiology is likely multifactorial and not yet understood. At present, oral nimodipine has an established role in the management of DCI, along with maintenance of euvolemia and induced hypertension. Following SAH, hypernatremia, although less common than hyponatremia, is a predictor of poor neurological outcome.

Conflict of interest statement

The author has no funding or conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Circle of Willis. Source: Chiu et al. Reprinted with permission from Children’s Hospital of Wisconsin. https://www.chw.org/display/PPF/DocID/48513/Nav/1/router.asp.

References

    1. de Rooij NK, Linn FH, van der Plas JA, et al. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365–1372.
    1. Vlak MH, Algra A, Brandenburg R, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10:626–636.
    1. Wermer MJ, van der Schaaf IC, Algra A, et al. Risk of rupture of unruptured intracranial aneurysms in relation to patient and aneurysm characteristics: an updated meta-analysis. Stroke. 2007;38:1404–1410.
    1. Ingall T, Asplundh K, Mähönen M, et al. A multinational comparison of subarachnoid hemorrhage in the WHO MONICA stroke study. Stroke. 2000;31:1054–1061.
    1. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369:306–318.
    1. Sandvei MS, Mathiesen EB, Vatten LJ, et al. Incidence and mortality of aneurysmal subarachnoid hemorrhage in two Norwegian cohorts, 1984-2007. Neurology. 2011;77:1833–1839.
    1. Fischer T, Johnsen SP, Pedersen L, et al. Seasonal variation in hospitalization and case fatality of subarachnoid hemorrhage—a nationwide Danish study on 9,367 patients. Neuroepidemiology. 2005;24:32–37.
    1. Koffijberg H, Buskens E, Granath F, et al. Subarachnoid haemorrhage in Sweden 1987-2002: regional incidence and case fatality rates. J Neurol Neurosurg Psychiatry. 2008;79:294–299.
    1. The ACROSS Group. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study. Stroke. 2000;31:1843–1850.
    1. Ie Roux AA, Wallace MC. Outcome and cost of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21:235–246.
    1. Alleyne CH., Jr Aneurysmal subarachnoid hemorrhage: Have outcomes really improved? Neurology. 2010;74:1486–1487.
    1. Rose MJ. Aneurysmal subarachnoid hemorrhage: an update on the medical complications and treatments strategies seen in these patients. Curr Opin Anaesthesiol. 2011;24:500–507.
    1. Bederson JB, Connolly ES, Jr, Batjer HH, et al. American Heart Association: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994–1025.
    1. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006;355:928–939.
    1. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain. 2001;124Pt:2249–278.
    1. Priebe HJ. Aneurysmal subarachnoid haemorrhage and the anaesthetist. Br J Anaesth. 2007;99:102–118.
    1. Rinkel GJ, Djibuti M, Algra A, et al. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 1998;29:251–256.
    1. Feigin VL, Rinkel GJ, Lawes CM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 2005;36:2773–2780.
    1. Ellamushi HE, Grieve JP, Jäger HR, et al. Risk factors for the formation of multiple intracranial aneurysms. J Neurosurg. 2001;94:728–732.
    1. The International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention. N Engl J Med. 1998;339:1725–1733.
    1. Ronkainen A, Hernesniemi J, Puranen M, et al. Familial intracranial aneurysms. Lancet. 1997;349:380–384.
    1. Bor AS, Rinkel GJ, Adami J, et al. Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study. Brain. 2008;131Pt 102662–2665.
    1. Suarez JI, Tarr RW, Selman WR. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387–396.
    1. Eden SV, Meurer WJ, Sánchez BN, et al. Gender and ethnic differences in subarachnoid hemorrhage. Neurology. 2008;71:731–735.
    1. Labovitz DL, Halim AX, Brent B, et al. Subarachnoid hemorrhage incidence among Whites, Blacks and Caribbean Hispanics: the Northern Manhattan Study. Neuroepidemiology. 2006;26:147–150.
    1. Schievink WI, Torres VE, Piepgras DG, et al. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc of Nephrol. 1992;3:88–95.
    1. Rinkel GJ. Natural history, epidemiology and screening of unruptured intracranial aneurysms. J Neuroradiol. 2008;35:99–103.
    1. Pepin M, Schwarze U, Superti-Furga A, et al. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673–680.
    1. Schievink WI, Parisi JE, Piepgras DG, et al. Intracranial aneurysms in Marfan’s syndrome: an autopsy study. Neurosurgery. 1997;41:866–870.
    1. Wiebers DO, Whisnant JP, Huston J, III, et al. International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103–110.
    1. Drake CG, Peerless SJ. Giant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1965-1992. J Neurosurg. 1997;87:141–162.
    1. Day AL, Gaposchkin CG, Yu CJ, et al. Spontaneous fusiform middle cerebral artery aneurysms: characteristics and a proposed mechanism of formation. J Neurosurg. 2003;99:228–240.
    1. Nahed BV, DiLuna ML, Morgan T, et al. Hypertension, age and location predict rupture of small intracranial aneurysms. Neurosurgery. 2005;57:676–683.
    1. Juvela S. Prehemorrhage risk factors for fatal intracranial aneurysm rupture. Stroke. 2003;34:1852–1857.
    1. Taylor CL, Yuan Z, Selman WR, et al. Cerebral arterial aneurysm formation and rupture in 20,767 elderly patients: hypertension and other risk factors. J Neurosurg. 1995;83:812–819.
    1. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg. 2008;108:1052–1060.
    1. Nanda A, Vannemreddy PS, Polin RS, et al. Intracranial aneurysms and cocaine abuse: analysis of prognostic indicators. Neurosurgery. 2000;46:1063–1069.
    1. Loewenstein JE, Gayle SC, Duffis EJ, et al. The natural history and treatment options for unruptured intracranial aneurysms. Int J Vasc Med. 2012;2012:898052.
    1. UCAS Japan Investigators. Morita A, Kirino T, Hashi K. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med. 2012;366:2474–2482.
    1. Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357:1821–1828.
    1. Keedy A. An overview of intracranial aneurysms. McGill J Med. 2006;9:141–146.
    1. Park JH, Park SK, Kim TH, et al. Anterior communicating artery aneurysm related to visual symptoms. J Korean Neurosurg Soc. 2009;46:232–238.
    1. Linskey ME, Sekhar LN, Hirsch WL, Jr, et al. Aneurysms of the intracavernous carotid artery: natural history and indications for treatment. Neurosurgery. 1990;26:933–937.
    1. Perry JJ, Stiell IG, Sivilotti ML, et al. High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. BMJ. 2010;341:c5204.
    1. Davenport R. Acute headache in the emergency department. J Neurol Neurosurg Psychiatry. 2002;72suppl 2ii33–ii37.
    1. Ostergaard JR. Headache as a warning symptom of impending aneurysmal subarachnoid hemorrhage. Cephalalgia. 1991;11:53–55.
    1. Verweij RD, Wijdicks EF, van Gijn J. Warning headache in aneurysmal subarachnoid hemorrhage. A case-control study. Arch Neurol. 1988;45:1019–1020.
    1. Ritz R, Reif J. Comparison of prognosis and complications after warning leaks in subarachnoidal hemorrhage-experience with 214 patients following aneurysm clipping. Neurol Res. 2005;27:620–624.
    1. Beck J, Raabe A, Szelenyi A, et al. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2006;37:2733–2737.
    1. Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care. 2005;2:110–118.
    1. Broderick JP, Brott TG, Duldner JE, et al. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke. 1994;25:1342–1347.
    1. Kassell NF, Torner JC, Haley EC, Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. J Neurosurg. 1990;73:18–36.
    1. Edlow JA, Caplan LR. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage. N Engl J Med. 2000;342:29–36.
    1. Manno EM. Subarachnoid hemorrhage. Neurol Clin. 2004;22:347–366.
    1. McCormack RF, Hutson A. Can computed tomography angiography of the brain replace lumbar puncture in the evaluation of acute-onset headache after a negative noncontrast cranial computed tomography scan? Acad Emerg Med. 2010;17:444–451.
    1. Westerlaan HE, van Dijk JM, Jansen-van der Weide MC, et al. Intracranial aneurysms in patients with subarachnoid hemorrhage: CT angiography as a primary examination tool for diagnosis—systematic review and meta-analysis. Radiology. 2011;258:134–145.
    1. Sidman R, Connolly E, Lemke T. Subarachnoid hemorrhage diagnosis: lumbar puncture is still needed when the computed tomography scan is normal. Acad Emerg Med. 1996;3:827–831.
    1. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1–9.
    1. Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery. 2006;59:21–27.
    1. Nomura Y, Kawaguchi M, Yoshitani K, et al. Retrospective analysis of predictors of cerebral vasospasm after ruptured cerebral aneurysm surgery: influence of the location of subarachnoid blood. J Anesth. 2010;24:1–6.
    1. Jeon IC, Chang CH, Choi BY, et al. Cardiac troponin 1 elevation in patients with aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc. 2009;46:99–102.
    1. Naidech AM, Kreiter KT, Janjua N, et al. Cardiac troponin elevation, cardiovascular morbidity and outcome after subarachnoid hemorrhage. Circulation. 2005;112:2851–2856.
    1. Mashaly HA, Provencio JJ. Inflammation as a link between brain injury and heart damage: the model of subarachnoid hemorrhage. Cleve Clin J Med. 2008;75suppl 2S26–S30.
    1. Ibrahim GM, Macdonald RL. Electrocardiographic changes predict angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2012;43:2102–2107.
    1. Jain R, Deveikis J, Thompson BG. Management of patients with stunned myocardium associated with subarachnoid hemorrhage. Am J Neuroradiol. 2004;25:126–129.
    1. Kono T, Morita H, Kuroiwa T, et al. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol. 1994;24:636–640.
    1. Mayer SA, Fink ME, Homma S, et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage. Neurology. 1994;44:815–820.
    1. Muroi C, Keller M, Pangalu A, et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2008;20:188–192.
    1. Davison DL, Terek M, Chawla LS. Neurogenic pulmonary edema. Crit Care. 2012;16:212.
    1. Connolly ES, Jr, Rabinstein AA, Carhuapoma JR, et al. on behalf of American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovasular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–1737.
    1. Diringer MN, Bleck TP, Claude Hemphill J, III, et al. Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–240.
    1. Anderson CS, Heeley E, Huang Y, et al. INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355–2365.
    1. Butcher KS, Jeerakathil T, Hill M, et al. for the ICH ADAPT Investigators. The Intracerebral Haemorrhage Acutely Decreasing Arterial Pressure Trial (ICH ADAPT): Final results. International Stroke Conference Oral Abstracts. Stroke. 2013;44:A113.
    1. Qureshi AI, Palesch YY. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011;15:559–576.
    1. Woloszyn AV, McAllen KJ, Figueroa BE, et al. Retrospective evaluation of nicardipine versus labetalol for blood pressure control in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2012;16:376–380.
    1. Kruyt ND, Biessels GJ, de Haan RJ, et al. Hyperglycemia and clinical outcome in aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke. 2009;40:e424–e430.
    1. Dorhout Mees SM, van Dijk GW, Algra A, et al. Glucose levels and outcome after subarachnoid hemorrhage. Neurology. 2003;61:1132–1133.
    1. Frontera JA, Fernandez A, Claassen J, et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke. 2006;37:199–203.
    1. Pasternak JJ, McGregor DG, Schroeder DR, et al. IHAST Investigators. Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc. 2008;83:406–417.
    1. Latorre JG, Chou SH, Nogueira RG, et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke. 2009;40:1644–1652.
    1. Phillips TJ, Dowling RJ, Yan B, et al. Does treatment of ruptured intracranial aneurysms within 24 hours improve clinical outcome? Stroke. 2011;42:1936–1945.
    1. de Gans K, Nieuwkamp DJ, Rinkel GJ, et al. Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery. 2002;50:336–340.
    1. Nieuwkamp DJ, de Gans K, Algra A, et al. Timing of aneurysm surgery in subarachnoid haemorrhage—an observational study in The Netherlands. Acta Neurochir (Wein). 2005;147:815–821.
    1. Siddiq F, Chaudhry SA, Tummala RP, et al. Factors and outcomes associated with early and delayed aneurysm treatment in subarachnoid hemorrhage patients in the United States. Neurosurgery. 2012;71:670–678.
    1. Starke RM, Kim GH, Fernandez A, et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysmal rebleeding after subarachnoid hemorrhage. Stroke. 2008;39:2617–2621.
    1. Hillman J, Fridriksson S, Nilsson O, et al. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97:771–778.
    1. Roos Y. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology. 2000;54:77–82.
    1. Chwajol M, Starke RM, Kim GH, et al. Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage. Neurocrit Care. 2008;8:418–426.
    1. Harrigan MR, Rajneesh KF, Ardelt AA, et al. Short-term antifibrinolytic therapy before aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery. 2010;67:935–940.
    1. Baharoglu MI, Germans MR, Rinkel GJ, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2013;8:CD001245.
    1. Molyneux AJ, Kerr RS, Stratton I, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. Lancet. 2002;360:1267–1274.
    1. Molyneux AJ, Kerr RS, Yu LM, et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized comparison of effects on survival, dependency, seizures, rebleeding, subgroups and aneurysm occlusion. Lancet. 2005;366:809–817.
    1. Molyneux AJ, Kerr RS, Birks J, et al. ISAT Collaborators. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardized mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol. 2009;8:427–433.
    1. Mitchell P, Kerr R, Mendelow AD, et al. Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the International Subarachnoid Aneurysm Trial? J Neurosurg. 2008;108:437–442.
    1. Johnston SC, Dowd CF, Higashida RT, et al. CARAT Investigators. Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke. 2008;39:120–125.
    1. van Rooij WJ, Sluzewski M. Opinion: Imaging follow-up after coiling of intracranial aneurysms. Am J Neuroradiol. 2009;30:1646–1648.
    1. Ogilvy CS. Neurosurgical clipping versus endovascular coiling of patients with ruptured intracranial aneurysms. Stroke. 2003;34:2540–2542.
    1. Sade B, Mohr G. Critical appraisal of the International Subarachnoid Aneurysm Trial (ISAT). Neurol India. 2004;52:32–35.
    1. Quinn TJ, Dawson J, Walters MR, et al. Reliability of the modified Rankins Scale: a systemic review. Stroke. 2009;40:3393–3395.
    1. Smith GA, Dagostino P, Maltenfort MG, et al. Geographic variation and regional trends in adoption of endovascular techniques for cerebral aneurysms. J Neurosurg. 2011;114:1768–1777.
    1. McDougall CG, Spetzler RF, Zabramski JM, et al. The Barrow Ruptured Aneurysm Trial. J Neurosurg. 2012;116:135–144.
    1. Spetzler RF, McDougall CG, Albuquerque FC, et al. The Barrow Ruptured Aneurysm Trial: 3-year results. J Neurosurg. 2013;119:146–157.
    1. Darsaut TE, Jack AS, Kerr RS, et al. International Subarachnoid Aneurysm Trial - ISAT part II: study protocol for a randomized controlled trial. Trials. 2013;14:156.
    1. Higashida RT, Lahue BJ, Torbey MT, et al. Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. Am J Neuroradiol. 2007;28:146–151.
    1. Raymond J, Darsaut TE, Molyneux AJ. On behalf of the TEAM collaborative Group. A trial on unruptured intracranial aneurysms (the TEAM trial): results, lessons from a failure and the necessity for clinical care trials. Trials. 2011;12:64.
    1. Mordasini P, Schroth G, Guzman R, et al. Endovascular treatment of posterior circulation cerebral aneurysms by using Guglielmi detachable coils: a 10-year single-center experience with special regard to technical development. Am J Neuroradiol. 2005;26:1732–1738.
    1. Sato E, Konishi Y, Shimada A, et al. Applications and roles of coil embolization and/or clipping in the treatment of cerebral aneurysm. Interv Neuroradiol. 2006;12supp 177–85.
    1. Peluso JP, van Rooij WJ, Sluzewski M, et al. Coiling of basilar tip aneurysms: results of 154 consecutive patients with emphasis on recurrent hemorrhage and re-treatment during mid- and long-term follow-up. J Neurol Neurosurg Psychiatry. 2008;79:706–711.
    1. Chalouhi N, Jabbour P, Gonzalez LF, et al. Safety and efficacy of endovascular treatment of basilar tip aneurysms by coiling with and without stent assistance: a review of 235 cases. Neurosurgery. 2012;71:785–794.
    1. Diaz FG, Ohaegbulam S, Dujovny M, et al. Surgical alternatives in the treatment of cavernous sinus aneurysms. J Neurosurg. 1989;71:846–853.
    1. van der Schaaf IC, Brilstra EH, Buskens E, et al. Endovascular treatment of aneurysms in the cavernous sinus: a systematic review on balloon occlusion of the parent vessel and embolization with coils. Stroke. 2002;33:313–318.
    1. van Rooij WJ. Endovascular treatment of cavernous sinus aneurysms. Am J Neuroradiol. 2012;33:323–326.
    1. Vendrell JF, Menjot N, Costalat V, et al. Endovascular treatment of 174 middle cerebral artery aneurysms: clinical outcome and radiological results at long-term follow-up. Radiology. 2009;253:191–198.
    1. Vendrell JF, Costalat V, Brunel H, et al. Stent-assisted coiling of complex middle cerebral artery aneurysms: initial and midterm results. Am J Neuroradiol. 2011;32:259–263.
    1. Doerfler A, Wanke I, Goericke SL, et al. Endovascular treatment of middle cerebral artery aneurysms with electrolytically detachable coils. Am J Neuroradiol. 2006;27:513–520.
    1. Quadros RS, Gallas S, Noudel R, et al. Endovascular treatment of middle cerebral artery aneurysms as first option: a single center experience of 92 aneurysms. Am J Neuroradiol. 2007;28:1567–1572.
    1. Kim BM, Kim DI, Park SI, et al. Coil embolization of unruptured middle cerebral artery aneurysms. Neurosurgery. 2011;68:346–354.
    1. Kim KH, Cha KC, Kim JS, et al. Endovascular coiling of middle cerebral artery aneurysms as an alternative to surgical clipping. J Clin Neurosci. 2013;20:520–522.
    1. Gonzalez NR, Dusick JR, Duckwiler G, et al. Endovascular coiling of intracranial aneurysms in elderly patients: report of 205 treated aneurysms. Neurosurgery. 2010;66:714–721.
    1. D’Urso PI, Lanzino G, Cloft HJ, et al. Flow diversion for intracranial aneurysms: a review. Stroke. 2011;42:2363–2368.
    1. Lanzino G. Flow diversion of intracranial aneurysms. J Neurosurg. 2013;118:405–406.
    1. Brinjikji W, Murad MH, Lanzino G, et al. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013;44:442–447.
    1. Alderazi YJ, Shastri D, Kass-Hout T, et al. Flow diverters for intracranial aneurysms. Stroke Res Treat. 2014;2014:415653.
    1. Arrese I, Sarabia R, Pintado R, et al. Flow-diverter devices for intracranial aneurysms: systematic review and meta-analysis. Neurosurgery. 2013;73:193–200.
    1. Jabbour P, Chalouhi N, Tjoumakaris S, et al. The Pipeline Embolization Device: learning curve and predictors of complications and aneurysm obliteration. Neurosurgery. 2013;73:113–120.
    1. Piano M, Valvassori L, Quilici L, et al. Midterm and long-term follow-up of cerebral aneurysms treated with flow diverter devices: a single-center experience. J Neurosurg. 2013;118:408–416.
    1. Becske T, Kallmes DF, Saatci I, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013;267:858–868.
    1. Murthy SB, Shah S, Shastri A, et al. The silk flow diverter in the treatment of intracranial aneurysms. Clin Neurosci. 2014;21:203–206.
    1. Wakhloo AJ, Lylyk P, de Vries J, et al. the Surpass study group. Surpass flow diverter for endovascular treatment of intracranial aneurysms—A multicenter preliminary clinical and angiographic experience in 161 patients with 186 aneurysms. International Stroke Conference oral abstracts. Stroke. 2014;45:A120.
    1. Jaeger M, Schuhmann MU, Soehle M, et al. Continuous monitoring of cerebrovascular autoregulation after subarachnoid hemorrhage by brain tissue oxygen pressure reactivity and its relation to delayed cerebral infarction. Stroke. 2007;38:981–986.
    1. Jaeger M, Soehle M, Schuhmann MU, et al. Clinical significance of impaired cerebrovascular autoregulation after severe aneurysmal subarachnoid hemorrhage. Stroke. 2012;43:2097–2101.
    1. Sponheim S, Skraastad Ø, Helseth E, et al. Effects of 0.5 and 1.0 MAC isoflurane, sevoflurane and desflurane on intracranial and cerebral perfusion pressures in children. Acta Aneaesthesiol Scand. 2003;47:932–938.
    1. Fraga M, Rama-Maceiras P, Rodi S, et al. The effects of isoflurane and desflurane on intracranial pressure, cerebral perfusion pressure, and cerebral arteriovenous oxygen content difference in normocapnic patients with supratentorial brain tumors. Anesthesiology. 2003;98:1085–1090.
    1. Holmström A, Akeson J. Desflurane induces more cerebral vasodilatation than isoflurane at the same A-line autoregressive index level. Acta Anaesthesiol Scand. 2005;49:754–758.
    1. Matta BF, Heath KJ, Tipping K, et al. Direct cerebral vasodilatory effects of sevoflurane and isoflurane. Anesthesiology. 1999;91:667–668.
    1. Magni G, Rosa IL, Melillo G, et al. A comparison between sevoflurane and desflurane anesthesia in patients undergoing craniotomy for supratentorial intracranial surgery. Anesth Analg. 2009;109:567–571.
    1. Gauthier A, Girard F, Boudreault D, et al. Sevoflurane provides faster recovery and postoperative neurological assessment than isoflurane in long-duration neurosurgical cases. Anesth Analg. 2002;95:1384–1388.
    1. Petersen KD, Landsfeldt U, Cold GE, et al. Intracranial pressure and cerebral hemodynamic in patients with cerebral tumors: a randomized prospective study of patients subjected to craniotomy in propofol-fentanyl, or sevoflurane-fentanyl anesthesia. Anesthesiology. 2003;98:329–336.
    1. Conti A, Lacopino DG, Fodale V, et al. Cerebral haemodynamic changes during propofol-remifentanil or sevoflurane anesthesia: transcranial Doppler study under bispectral index monitoring. Br J Anaesth. 2006;97:333–339.
    1. Lauta E, Abbinante C, Del Gaudio A, et al. Emergence times are similar with sevoflurane and total intravenous anesthesia: results of a multicenter RCT of patients scheduled for supratentorial craniotomy. J Neurosurg Anesthesiol. 2010;22:110–118.
    1. Citerio G, Pesenti A, Latini R, et al. NeuroMorfeo Study Group. A multicentre, randomised, open-label, controlled trial evaluating equivalence of inhalational and intravenous anaesthesia during elective craniotomy. Eur J Anaesthesiol. 2012;29:371–379.
    1. Magni G, Baisi F, La Rosa I, et al. No difference in emergence time and early cognitive function between sevoflurane-fentanyl and propofol-remifentanil in patients undergoing craniotomy for supratentorial intracranial surgery. J Neurosurg Anesthesiol. 2005;17:134–138.
    1. Uchida K, Yasunaga H, Sumitani M, et al. Effects of Remifentanil on in-hospital mortality and length of stay following clipping of intracranial aneurysm: a propensity score-matched analysis. J Neurosurg Anesthesiol. 2014;26:291–298.
    1. Gelb AW, Craen RA, Rao GS, et al. Does hyperventilation improve operating condition during supratentorial craniotomy? A multicenter randomized crossover trial. Anesth Analg. 2008;106:585–594.
    1. Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75:731–739.
    1. Bouma GJ, Muizelaar JP, Stringer WA, et al. Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon enhanced computerized tomography. J Neurosurg. 1992;77:360–368.
    1. Sioutous PJ, Orozco JA, Carter LP, et al. Continuous regional cerebral cortical blood flow monitoring in head-injured patients. Neurosurgery. 1995;36:943–949.
    1. Marion DW, Darby J, Yonas H. Acute regional cerebral blood flow changes caused by severe head injuries. J Neurosurg. 1991;74:407–414.
    1. Coles JP, Fryer TD, Coleman MR, et al. Hyperventilation following head injury: effect on ischemic burden and cerebral oxidative metabolism. Crit Care Med. 2007;35:568–578.
    1. Stocchetti N, Al Maas, Chieregato A, et al. Hyperventilation in head injury: a review. Chest. 2005;127:1812–1827.
    1. Rothenberg DM, O’Connor CJ, Tuma KE.Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL. Neurosurgical anesthesia. Neurosurgical Anesthesia, Miller’s Anesthesia. 2009:7th edPhiladelphia, Churchill-Livingstone: Elsevier; Publishers;2071.
    1. Moore AJ, Newell DW. Tumor Neurosurgery Principles and Practice. 2006London, United Kingdom: Springer-Verlag; London Limited Publishers;88.
    1. Wu CT, Chen LC, Kuo CP, et al. A comparison of 3% hypertonic saline and mannitol for brain relaxation during elective supratentorial brain tumor surgery. Anesth Analg. 2010;110:903–907.
    1. Demneri M, Hoxha A, Pillika K, et al. Comparison of 20% mannitol and 7.5% hypertonic saline for supratentorial craniotomy. Eur J Anesth. 2011;28:106–107.
    1. Mortazavi MM, Romeo AK, Deep A, et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg. 2012;116:210–221.
    1. White H, Cook D, Venkatesh B. The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth Analg. 2006;102:1836–1846.
    1. Wicks RT, Pradilla G, Raza SM, et al. Impact of changes in intraoperative somatosensory evoked potentials on stroke rates after clipping of intracranial aneurysms. Neurosurgery. 2012;70:1114–1124.
    1. Parenti G, Marconi F, Fiori L. Electrophysiological (EEG-SSEP) monitoring during middle cerebral aneurysm surgery. J Neurosurg Sci. 1996;40:195–205.
    1. Lopéz JR, Chang SD, Steinberg GK. The use of electrophysiological monitoring in the intraoperative management of intracranial aneurysms. J Neurol Neurosurg Psychiatry. 1999;66:189–196.
    1. Manninen PH, Patterson S, Lam AM, et al. Evoked potential monitoring during posterior fossa aneurysm surgery: a comparison of two modalities. Can J Anaesth. 1994;41:92–97.
    1. Szelényi A, Langer D, Kothbauer K, et al. Monitoring of muscle motor evoked potentials during cerebral aneurysm surgery: intraoperative changes and postoperative outcome. J Neurosurg. 2006;105:675–681.
    1. Guo L, Gelb AW. The use of motor evoked potential monitoring during cerebral aneurysm surgery to predict pure motor deficits due to subcortical ischemia. Clin Neurophysiol. 2011;122:648–655.
    1. Irie T, Yoshitani K, Ohnishi Y, et al. The efficacy of motor evoked potentials on cerebral aneurysm surgery and new onset postoperative motor deficits. J Neurosurg Anesthesiol. 2010;22:247–251.
    1. Yeon JY, Seo DW, Hong SC, et al. Transcranial motor evoked potential monitoring during the surgical clipping of unruptured intracranial aneurysms. J Neurol Sci. 2010;293:29–34.
    1. Todd MM, Hindman BJ, Clarke WR, et al. Introperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135–145.
    1. Choi R, Andres RH, Steinberg GK, et al. Intraoperative hypothermia during vascular neurosurgical procedures. Neurosurg Focus. 2009;26:E 24.
    1. Komotar RJ, Jones JE, Connolly ES., Jr Introperative hypothermia for Aneurysm surgery Trial (IHAST). Neurosurgery. 2005;56:N9–N10.
    1. Li LR, You C, Chaudhury B. Cooling the brain during surgery for preventing death or severe disability in patients with brain aneurysms. Cochrane Summ. 2012;2:CD008445.
    1. Suarez JI, Martin RH, Calvillo E, et al. ALISAH Investigators. The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurological outcomes. Stroke. 2012;43:683–690.
    1. SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health. Myburgh J, Cooper DJ, Finfer S, et al. Saline or albumin for Fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357:874–884.
    1. Cooper DJ, Myburgh J, Heritier S, et al. SAFE-TBI Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma. 2013;30:512–518.
    1. Ka-Hung Pang P, Chan K, Zhu X, et al. Use of elective temporary clips in preventing intraoperative cerebral aneurysm rupture. Ann Coll Surg Hong Kong. 2004;8920:44–48.
    1. Lavine SD, Masri LS, Levy ML, et al. Temporary occlusion of the middle cerebral artery in intracranial aneurysm surgery: time limitation and advantage of brain protection. J Neurosurg. 1997;87:817–824.
    1. Schick U, Döhnert J, Meyer JJ, et al. Effects of temporary clips on somatosensory evoked potentials in aneurysm surgery. Neurocrit Care. 2005;2:141–149.
    1. Samson D, Batjer HH, Bowman G, et al. A clinical study of the parameters and effects of temporary arterial occlusion in the management of intracranial aneurysms. Neurosurgery. 1994;34:22–28.
    1. Woertgen C, Rothoerl RD, Albert R, et al. Effects of temporary clipping during aneurysm surgery. Neurol Res. 2008;30:542–546.
    1. Ogilvy CS, Carter BS, Kaplan S, et al. Temporary vessel occlusion for aneurysm surgery: risk factors for stroke in patients protected by induced hypothermia and hypertension and intravenous mannitol administration. J Neurosurg. 1996;84:785–791.
    1. Hindman BJ, Bayman EO, Pfisterer WK, et al. IHAST Investigators. No association between intraoperative hypothermia or supplemental protective drug and neurological outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial. Anesthesiology. 2010;112:86–101.
    1. Bebawy JF, Gupta DK, Bendok BR, et al. Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation: dose-response data and safety profile. Anesth Analg. 2010;110:1406–1411.
    1. Bendok BR, Gupta DK, Rahme RJ, et al. Adenosine for temporary flow arrest during intracranial aneurysm surgery: a single-center retrospective review. Neurosurgery. 2011;69:815–821.
    1. Guinn NR, McDonagh DL, Borel CO, et al. Adenosine-induced transient asystole for intracranial aneurysm surgery: a retrospective review. J Neurosurg Anesthesiol. 2011;23:35–40.
    1. Khan SA, McDonagh DL, Adogwa O, et al. Perioperative cardiac complications and 30-day mortality in patients undergoing intracranial aneurysmal surgery with adenosine-induced flow arrest: a retrospective comparative study. Neurosurgery. 2014;74:267–272.
    1. Khan AS, Nimjee SM, Guinn NN, et al. The use of adenosine in cerebral aneurysm clipping: a review. Curr Anesthesiol Rep. 2013;3:210–213.
    1. Roessler K, Krawagna M, Dörfler A, et al. Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature. Neurosurg Focus. 2014;36:E7.
    1. Washington CW, Zipfel GJ, Chicoine MR, et al. Comparing indocyanine green videoangiography to the gold standard of intraoperative digital subtraction angiography used in aneurysm surgery. J Neurosurg. 2013;118:420–427.
    1. Kan P, Jahshan S, Yashar P, et al. Feasibility, safety, and periprocedural complications associated with endovascular treatment of selected ruptured aneurysms under conscious sedation and local anesthesia. Neurosurgery. 2013;72:216–220.
    1. Lee CZ, Young WL. Anesthesia for endovascular neurosurgery and interventional neuroradiology. Anesthesiol Clin. 2012;30:127–147.
    1. Talke PO, Sharma D, Heyer EJ, et al. Society for Neuroscience in Anesthesiology and Critical Care Expert Consensus Statement: Anesthetic management of endovascular treatment for acute ischemic stroke: Endorsed by the Society of NeuroInterventional Surgery and the Neurocritical Care Society. J Neurosurg Anesthesiol. 2014;26:95–108.
    1. Doerfler A, Wanke I, Egelhof T, et al. Aneurysmal rupture during embolization with Guglielmi detachable coils: causes, management and outcome. Am J Neuroradiol. 2001;22:1825–1832.
    1. van Rooij WJ, Sluzewski M, Beute GN, et al. Procedural complications of coiling of ruptured intracranial aneurysms: incidence and risk factors in a consecutive series of 681 patients. Am J Neuroradiol. 2006;27:1498–1501.
    1. Levy E, Koebbe CJ, Horowitz MB, et al. Rupture of intracranial aneurysms during endovascular coiling management and outcomes. Neurosurgery. 2001;49:807–813.
    1. McDougall CG, Halback VV, Dowd CF, et al. Causes and management of aneurysmal hemorrhage occurring during embolization with Guglielmi detachable coils. J Neurosurg. 1998;89:87–92.
    1. Layton KF, Cloft HJ, Kallmes DF. Cerebral aneurysm perforations during treatment with detachable coils. Use of remodeling balloon inflation to achieve hemostasis. Interv Neuroradiol. 2006;12:31–35.
    1. Rabinstein AA, Pichelmann MA, Friedman JA, et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg. 2003;98:319–325.
    1. Hoh BL, Topcuoglu MA, Singhal AB, et al. Effect of clipping, craniotomy or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2004;55:779–789.
    1. Dehdashti AR, Mermillod B, Rufenacht DA, et al. Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis. 2004;17:53–60.
    1. Goddard AJ, Raju PP, Gholkar A. Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome? J Neurol Neurosurg Psychiatry. 2004;75:868–872.
    1. de Oliveira JG, Beck J, Ulrich C, et al. Comparison between clipping and coiling on the incidence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurosurg Rev. 2007;30:22–31.
    1. deRooji NK, Rinkel GJ, Dankbaar JW, et al. Delayed cerebral ischemia after subarachnoid hemorrhage; a systemic review of clinical, laboratory, and radiological predictors. Stroke. 2013;44:43–54.
    1. Budohoski KP, Czosnyka M, Smielewski P, et al. Impairment of cerebral autoregulation predicts delayed cerebral ischemia after subarachnoid hemorrhage: a prospective observational study. Stroke. 2012;43:3230–3237.
    1. Rowland MJ, Hadjipavlou G, Kelly M, et al. Delayed cerebral ischemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth. 2012;109:315–329.
    1. Woitzik J, Dreier JP, Hecht N, et al. COSBID study group. Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012;32:203–212.
    1. Lauritzen M, Dreier JP, Fabricius M, et al. Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury. J Cereb Blood Flow Metab. 2011;31:17–35.
    1. Drier JP, Major S, Manning A, et al. COSBID study group. Cortical spreading ischaemia is a novel process involved in ischemic damage in patients with aneurysmal subarachnoid hemorrhage. Brain. 2009;132:1866–1881.
    1. Tam AK, Ilodigwe D, Mocco J, et al. Impact of systemic inflammatory response on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database. Neurocrit Care. 2010;13:182–189.
    1. Fountas KN, Tasiou A, Kapsalaki EZ, et al. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article. Neurosurg Focus. 2009;26:E22.
    1. Sarrafzadeh A, Schlenk F, Gericke C, et al. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;13:339–346.
    1. Muroi C, Hugelshofer M, Seule M, et al. Correlation among systemic inflammatory parameter, occurrence of delayed neurological deficits, and outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2013;72:367–375.
    1. McMahon CJ, Hopkins S, Vail A, et al. Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. Neurointerv Surg. 2013;5:512–517.
    1. Dorhout Mees SM, Rinkel GJE, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:514–515.
    1. Velat GJ, Kimball MM, Mocco JD, et al. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analysis in the literature. World Neurosurg. 2011;76:446–454.
    1. Barker FG, II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a meta-analysis. J Neurosurg. 1996;84:405–414.
    1. Haley EC, Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg. 1993;78:537–547.
    1. Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following subarachnoid hemorrhage. Neurocrit Care. 2006;4:68–76.
    1. Sen J, Belli A, Albon H, et al. Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2003;2:614–621.
    1. Muench E, Horn P, Bauhuf C, et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med. 2007;35:1844–1851.
    1. Harrigan MR. Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm. Crit Care. 2010;14:151.
    1. Dankbaar JW, Slooter AJ, Rinkel GJ, et al. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systemic review. Crit Care. 2010;14:R23.
    1. Treggiari MM. Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Hemodynamic management of subarachnoid hemorrhage. Neurocrit Care. 2011;15:329–335.
    1. Treggiari MM, Deem S. Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care. 2009;15:83–86.
    1. Rinkel GJE, Feigin VL, Algra A, et al. Hypervolemia in aneurysmal subarachnoid hemorrhage. Stroke. 2005;36:1104–1105.
    1. Chittiboina P, Conrad S, McCarthy P, et al. The evolving role of hemodilution in treatment of cerebral vasospasm: a historical perspective. World Neurosurg. 2011;75:660–664.
    1. Santillan A, Knopman J, Zink W, et al. Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2011;69:95–102.
    1. Eskridge JM, McAuliffe W, Song JK, et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery. 1998;42:510–517.
    1. Athar MK, Levine JM. Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurotherapeutics. 2012;9:37–43.
    1. Liu JK, Couldwell WT. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmsal subarachnoid hemorrhage. Neurocrit Care. 2005;2:124–132.
    1. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine and intra-arterial nicardipine. Neurosurg Clin N Am. 2005;16:501–516.
    1. McAuliffe W, Townsend M, Eskridge JM, et al. Intracranial pressure changes induced during papaverine infusion for treatment of vasospasm. J Neurosurg. 1995;83:430–434.
    1. Cross DT, III, Moran CJ, Angtuaco EE, et al. Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm. Am J Neuroradiol. 1998;19:1319–1323.
    1. Smith WS, Dowd CF, Johnston SC, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:2518–2522.
    1. Biondi A, Ricciardi GK, Puybasset L, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. Am J Neuroradiol. 2004;25:1067–1076.
    1. Cho WS, Kang HS, Kim JE, et al. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Interv Neuroradiol. 2011;17:169–178.
    1. Musahl C, Henkes H, Vajda Z, et al. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. Neurosurgery. 2011;68:1541–1547.
    1. Oran I, Cinar C. Continuous intra-arterial infusion of nimodipine during embolization of cerebral aneurysms associated with vasospasm. Am J Neuroradiol. 2008;29:291–295.
    1. Wolf S, Martin H, Landscheidt JF, et al. Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm. Neurocrit Care. 2010;12:346–351.
    1. Hui C, Lau KP. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid hemorrhage. Clin Radiol. 2005;60:1030–1036.
    1. Schmidt U, Bittner E, Pivi S, et al. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone. Anesth Analg. 2010;110:895–902.
    1. Fraticelli AT, Cholley BP, Losser MR, et al. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:893–898.
    1. Shankar JJ, dos Santos MP, Deus-Silva L, et al. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology. 2011;53:123–128.
    1. Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2008;108:458–463.
    1. Sehy JV, Holloway WE, Lin SP, et al. Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration. Am J Neuroradiol. 2010;31:1923–1928.
    1. The University of Texas Health Science Center, Houston. Intrarterial Vasospasm Trial (IVT) A Multi-Center Randomized Study. In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2014. Available at: .
    1. Abruzzo T, Moran C, Blackham KA, et al. Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurointerv Surg. 2012;4:169–177.
    1. van den Bergh WM, Algra A, van Kooten F, et al. MASH Study Group. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–1015.
    1. Westermaier T, Stetter C, Vince GH, et al. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Crit Care Med. 2010;38:1284–1290.
    1. Stippler M, Crago E, Levy El, et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg. 2006;105:723–729.
    1. Muroi C, Terzic A, Fortunati M, et al. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol. 2008;69:33–39.
    1. Dorhout Mees SM, Algra A, Vandertop WP, et al. MASH-2 Study Group. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomized placebo-controlled trial. Lancet. 2012;380:44–49.
    1. Wong GK, Poon WS, Chan MT, et al. IMASH Investigators. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 2010;41:921–926.
    1. Wong GK, Boet R, Poon WS, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis. Crit Care. 2011;15:R52.
    1. Zhao XD, Zhou YT, Zhang X, et al. A meta-analysis of treating subarachnoid hemorrhage with magnesium sulfate. J Clin Neurosci. 2009;16:1394–1397.
    1. Zhang S, Wang L, Liu M, et al. Tirilazad for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2010;17:CD006778.
    1. Macdonald RL, Kassell NF, Mayer S, et al. CONSCIOUS-1 Investigators. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39:3015–3021.
    1. Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomized, double blind, placebo-controlled phase 3 trial (CONSCIOUS -2). Lancet Neurol. 2011;10:618–625.
    1. Clazosentan in Aneurysmal Subarachnoid Hemorrhage (CONSCIOUS-3). In: [Internet]. Bethesda (MD): National Library of Medicine (US). 2009- 2012 Available at: .
    1. Kramer AH, Fletcher JJ. Statins in the management of aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 2010;12:285–296.
    1. Vergouwen MD, de Haan RJ, Vermeulen M, et al. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke. 2010;41:e47–e52.
    1. Kirkpatrick PJ, Turner CL, Smith C, et al. for the STASH Collaborators. Simvastatin in aneurysmal subarachnoid hemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 2014;13:666–675.
    1. van den Bergh WM, Algra A, Dorhout Mees SM, et al. MASH Study Group. Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study. Stroke. 2006;37:2326–2330.
    1. Dorhout Mees SM, van den Berg WM, Algra A, et al. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;17:CD 006184.
    1. Wurm G, Tomancok B, Nussbaumer K, et al. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg. 2004;106:97–103.
    1. Siironen J, Juvela S, Varis J, et al. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized double-blind placebo-controlled clinical trial. J Neurosurg. 2003;99:953–959.
    1. Amin-Hanjani S, Ogilvy CS, Barker FG., II Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery. 2004;54:326–335.
    1. Heiserman JE. MR angiography for the diagnosis of vasospasm after subarachnoid hemorrhage. Is it accurate? Is it safe? Am J Neuroradiol. 2000;21:1571–1572.
    1. Mills JN, Mehta V, Russin J, et al. Advanced imaging modalities in the detection of cerebral vasospasm. Neurol Res Int. 2013;2013:415960.
    1. Rigamonti A, Ackery A, Baker AJ. Transcranial Doppler monitoring in subarachnoid hemorrhage: a critical tool in critical care. Can J Anaesth. 2008;55:112–123.
    1. Lysakowski C, Walder B, Costanza MC, et al. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systemic review. Stroke. 2001;32:2292–2298.
    1. Saqqur M, Zygun D, Demchuk A. Role of transcranial Doppler in neurocritical care. Crit Care Med. 2007;35supplS216–S223.
    1. Marshall SA, Nyquist P, Ziai WC. The role of transcranial Doppler ultrasonography in the diagnosis and management of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21:291–303.
    1. Miller CM, Palestrant D, Schievink WI, et al. Prolonged transcranial Doppler monitoring after aneurysmal subarachnoid hemorrhage fails to adequately to predict ischemic risk. Neurocrit Care. 2011;15:387–392.
    1. Suarez JI, Al Qureshi, Yahia AB, et al. Symptomatic vaospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med. 2002;30:1348–1355.
    1. Vora YY, Suarez-Almazor M, Strinke DE, et al. Role of transcranial doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery. 1999;44:1237–1248.
    1. Fontera JA, Fernandez A, Schmidt JM, et al. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? Stroke. 2009;40:1963–1968.
    1. Wong JK, Poon WS. Clinical, transcranial Doppler ultrasound, radiological features and, prognostic significance of delayed cerebral ischemia. Acta Neurochir Suppl. 2013;115:9–11.
    1. Nakae R, Yokota H, Yoshioda D, et al. Transcranial Doppler ultrasonography for diagnosis of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: mean blood flow velocity ratio of the ipsilateral and contralateral middle cerebral arteries. Neurosurgery. 2011;69:876–883.
    1. Newell DW, Winn HR. Transcranial Doppler in cerebral vasospasm. Neurosurg Clin N Am. 1990;1:319–328.
    1. Sharma VK, Pereira AW, Chan BP. Vasospasm followed by diastolic flow reversal in the intracranial arteries after subarachnoid haemorrhage. J Clin Neurosci. 2007;14:389–391.
    1. Qureshi Al, Suri MF, Sung GY, et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;50:749–756.
    1. Sherlock M, O’Sullivan E, Agha A, et al. The incidence and pathophysiology of hyponatraemia after subarachnoid hemorrhage. Clin Endocrinol (Oxf). 2006;64:250–254.
    1. Audibert G, Steinmann G, de Talanc N, et al. Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg. 2009;108:1922–1928.
    1. Wartenberg KE, Mayer SA. Medical complications after subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21:325–338.
    1. Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14:182–187.
    1. Fisher LA, Ko N, Miss J, et al. Hypernatremia predicts adverse cardiovascular and neurological outcomes after SAH. Neurocrit Care. 2006;5:180–185.
    1. Kreitschmann-Andermahr I. Subarachnoid hemorrhage as a cause of hypopitutarism. Pituitary. 2005;8:219–225.
    1. Kreitschmann-Andermahr I, Hoff C, Niggemeier S, et al. Pituitary deficiency following aneurysmal subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry. 2003;74:1133–1135.
    1. Chiu Y, Drolet B, Seefeldt M, et al. Abnormalities of the Head and Neck Arteries (Cerebrovascular Abnormalities). In: PHACE Syndrome Handbook: A Guide for Parents and Physicians, Children's Hospital of Wisconsin. Milwaukee, WI. Available at: .

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera